| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |